NCR3 and gastrointestinal stromal tumor: One activating receptor, NKp30, was found to be particularly downregulated in peripheral and tumor-infiltrating NK cells in gastrointestinal sarcoma (GIST) when compared to the circulating NKp30+ NK cells of healthy volunteers [56].